The leading Russian pharmaceutical company Binnopharm Group has won in four nominations of the XXIV All-Russian open competition of pharmaceutical industry professionals "Platinum Ounce".
The company became the winner in the most important nomination of the competition "The largest manufacturers of medicines", beating the strongest competitors. In addition, the company received the "Ounce" in the nomination "Dynamics of the Year" in the nomination "Company. Supplies to the commercial sector." The project to create one of the largest R&D centers in Russia - the Center for Pharmaceutical Development of chemical synthesis products "Binnopharm Group" was noted separately. Rustem Muratov, CEO of Binnopharm Group, became the Manager of the Year in the Senior Manager sub-nomination.
Rustem Muratov, CEO of Binnopharm Group: "This year we won four nominations at once – this is more than in all the years of the company's existence combined. The market appreciated not only the overall results of the company, but also our efforts in certain areas that are important to us. Such a high assessment confirms our confident position in the market, the correctness of the chosen strategy and the excellent work of the team not only for us, but also for the industry. Recognition of colleagues and specialists is always an additional motivation for further growth at a high rate."
Yuri Krestinsky, Chairman of the Organizing Committee of the Platinum Ounce Competition: "We congratulate our colleagues from Binnopharm Group on such significant results. The Platinum Ounce traditionally celebrates those who are at the forefront of the industry. Today we see that Russian pharma is developing rapidly, and we have something to be proud of."
The nominees and winners of the Platinum Ounce professional competition are determined by representatives of the scientific community, reputable pharmaceutical market publications, and CEOs of pharmaceutical companies.
Please note that this press release is based on materials provided by the company. AK&M Information Agency shall not be held liable for its contents, nor for the legal and other consequences of its publication.
